Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Biological Therapies for Severe Asthma Endotypes
Corrado Pelaia, Giulia Pelaia, Claudia Crimi, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1064-1064
Open Access | Times Cited: 21

Showing 21 citing articles:

Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
Corrado Pelaia, Alida Benfante, Maria Teresa Busceti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3371-3371
Open Access | Times Cited: 27
Pediatric obesity and severe asthma: Targeting pathways driving inflammation
Maria Di Cicco, Michele Ghezzi, Ahmad Kantar, et al.
Pharmacological Research (2023) Vol. 188, pp. 106658-106658
Open Access | Times Cited: 18
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma
Alessandro Vatrella, Angelantonio Maglio, Corrado Pelaia, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2181-2181
Open Access | Times Cited: 25
Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma
Sylwia Smolińska, Darío Antolín‐Amérigo, Florin‐Dan Popescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12725-12725
Open Access | Times Cited: 14
Benralizumab affects NK cell maturation and proliferation in severe asthmatic patients
Laura Bergantini, Miriana d’Alessandro, Tommaso Pianigiani, et al.
Clinical Immunology (2023) Vol. 253, pp. 109680-109680
Open Access | Times Cited: 13
Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities
Alessandro Vatrella, Angelantonio Maglio
Expert Review of Respiratory Medicine (2025)
Closed Access
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting
Carolina Vitale, Angelantonio Maglio, Corrado Pelaia, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 985-985
Open Access | Times Cited: 9
scRNA-seq profiling of human granulocytes reveals expansion of developmentally flexible neutrophil precursors with mixed neutrophil and eosinophil properties in asthma
Nana-Fatima Haruna, Yuliya Politanska, Andrew R. Connelly, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 5, pp. 1184-1197
Closed Access | Times Cited: 2
Allergen Immunotherapy for the Prevention and Treatment of Asthma
Thierry Batard, Camille Taillé, Laurent Guilleminault, et al.
Clinical & Experimental Allergy (2024)
Open Access | Times Cited: 2
Metabolic and ionic control of T cells in asthma endotypes
Tobias Franz, Sabine Stegemann‐Koniszewski, Jens Schreiber, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 5, pp. C1300-C1307
Closed Access | Times Cited: 2
Type 2 severe asthma: pathophysiology and treatment with biologics
Corrado Pelaia, J. Mark Melhorn, Timothy S.C. Hinks, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 7, pp. 485-498
Closed Access | Times Cited: 1
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report
Antonio Maiorano, Chiara Lupia, Nicola Montenegro, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Automated, Point-of-Care mobile flow cytometry: Bringing the laboratory to the sample
Bernard N. Jukema, Thomas Pelgrim, Marcia Spoelder, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e28883-e28883
Open Access
Asma: uma revisão sobre a fisiopatologia e as novas abordagens terapêuticas
Ana Clara Ferreira Segato, Luan Linhares de Azeredo Coutinho, Hermínio Maurício da Rocha Sobrinho
Revista Eletrônica Acervo Saúde (2024) Vol. 24, Iss. 5, pp. e16439-e16439
Open Access
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways
Josuel Ora, Patrizia De Marco, Enrico Motta, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 5883-5883
Open Access
OSTEONECROSIS: A DISABLING DISEASE NOT TO BE IGNORED IN ASTHMA AND ATOPIC CONDITIONS
Chase Rupprecht, Guha Krishnaswamy
Annals of Allergy Asthma & Immunology (2024)
Closed Access
Special Issue on ‘Asthma and Allergic Inflammation’
Corrado Pelaia
Vaccines (2023) Vol. 11, Iss. 3, pp. 531-531
Open Access | Times Cited: 1
Uso y resultados del astegolimab en el manejo del asma severa: ¿qué se conoce?
Ivan David Lozada‐Martínez, Gonzalo Domínguez Alvarado, Fernando Torres Perez, et al.
Horizonte Médico (Lima) (2023) Vol. 23, Iss. 1, pp. e1948-e1948
Open Access
Advances in the study of the role of extraoral bitter taste receptors
Xiaohui Yu, Yanli Zhen, Ting Fang, et al.
Authorea (Authorea) (2023)
Open Access
Automated, Point-of-Care Mobile Flow Cytometry: Bringing the Laboratory to the Sample
Bernard N. Jukema, Thomas Pelgrim, Marcia Spoelder, et al.
(2023)
Open Access
Page 1

Scroll to top